Literature DB >> 29404783

Neuropathology and biochemistry of early onset familial Alzheimer's disease caused by presenilin-1 missense mutation Thr116Asn.

Stanislav Sutovsky1, Tomas Smolek2, Peter Turcani1, Robert Petrovic3, Petra Brandoburova4, Santosh Jadhav1, Petr Novak2, Johannes Attems5, Norbert Zilka6,7.   

Abstract

The majority (~ 55%) of early onset familial Alzheimer disease (FAD) is caused by mutations in the presenilin 1 gene (PSEN1). Here, we describe a family with early onset FAD with a missense mutation in the PSEN1 gene (Thr116Asn). Five family members developed dementia in the third decade of life. One subject underwent autopsy. The onset of clinical symptoms was at the age of 37 years and the disease progressed rapidly. The clinical picture was characterised by progressive memory impairment, amnestic aphasia, and gait disturbances. Neuropathological assessment revealed widespread β-amyloid (Thal phase 5) and tau (Braak stage 6) pathology. Abundant deposition of diffuse and cored plaques was distributed in cortical and subcortical areas, as well as in the cerebellum, while cotton wool plaques were observed mainly in the occipital cortex. Cerebral amyloid angiopathy was present throughout the brain. In the neocortex, tau pathology, especially neuropil threads, was more abundant in the frontal and occipital cortex and in the hippocampus. Proteomic analyses revealed that the pattern of sarkosyl-insoluble tau was similar to the one seen in sporadic AD. No α-synuclein or TDP-43 pathology was found either in cortical nor in subcortical areas. Here, we present the first comprehensive neuropathological and biochemical study of early onset FAD with a missense mutation Thr116Asn in the presenilin 1 gene. In contrast to other PS1-linked AD patients, the present subject developed cotton wool plaques which were not associated with spastic paraparesis.

Entities:  

Keywords:  Amyloid β; Familial Alzheimer’s disease; Presenilin 1; Tau

Mesh:

Substances:

Year:  2018        PMID: 29404783     DOI: 10.1007/s00702-018-1850-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  29 in total

1.  Novel mutations and repeated findings of mutations in familial Alzheimer disease.

Authors:  Ulrich Finckh; Christian Kuschel; Maria Anagnostouli; Efstratios Patsouris; George V Pantes; Stylianos Gatzonis; Elisabeth Kapaki; Panagiota Davaki; Katrin Lamszus; Dimitrios Stavrou; Andreas Gal
Journal:  Neurogenetics       Date:  2005-03-18       Impact factor: 2.660

2.  Cotton wool plaques in non-familial late-onset Alzheimer disease.

Authors:  T V Le; R Crook; J Hardy; D W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2001-11       Impact factor: 3.685

3.  Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update.

Authors:  G Raux; L Guyant-Maréchal; C Martin; J Bou; C Penet; A Brice; D Hannequin; T Frebourg; D Campion
Journal:  J Med Genet       Date:  2005-07-20       Impact factor: 6.318

4.  Alzheimer's disease with spastic paraparesis and 'cotton wool' plaques: two pedigrees with PS-1 exon 9 deletions.

Authors:  William S Brooks; John B J Kwok; Jillian J Kril; G Anthony Broe; Peter C Blumbergs; Anthony E Tannenberg; Phillipa J Lamont; Philippa Hedges; Peter R Schofield
Journal:  Brain       Date:  2003-04       Impact factor: 13.501

5.  Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease.

Authors:  Cees Mulder; Nicolaas A Verwey; Wiesje M van der Flier; Femke H Bouwman; Astrid Kok; Evert J van Elk; Philip Scheltens; Marinus A Blankenstein
Journal:  Clin Chem       Date:  2009-10-15       Impact factor: 8.327

Review 6.  Presenilin-1 mutations in Alzheimer's disease: an update on genotype-phenotype relationships.

Authors:  A J Larner
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

7.  The need to unify neuropathological assessments of vascular alterations in the ageing brain: multicentre survey by the BrainNet Europe consortium.

Authors:  Irina Alafuzoff; Ellen Gelpi; Safa Al-Sarraj; Thomas Arzberger; Johannes Attems; Istvan Bodi; Nenad Bogdanovic; Herbert Budka; Orso Bugiani; Elisabet Englund; Isidro Ferrer; Stephen Gentleman; Giorgio Giaccone; Manuel B Graeber; Tibor Hortobagyi; Romana Höftberger; James W Ironside; Kurt Jellinger; Nikolaos Kavantzas; Andrew King; Penelope Korkolopoulou; Gábor G Kovács; David Meyronet; Camelia Monoranu; Piero Parchi; Efstratios Patsouris; Wolfgang Roggendorf; Annemieke Rozemuller; Danielle Seilhean; Nathalie Streichenberger; Dietmar R Thal; Stephen B Wharton; Hans Kretzschmar
Journal:  Exp Gerontol       Date:  2012-06-15       Impact factor: 4.032

Review 8.  The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE.

Authors:  Rita J Guerreiro; Deborah R Gustafson; John Hardy
Journal:  Neurobiol Aging       Date:  2010-07-01       Impact factor: 4.673

9.  Unbiased estimates of cerebrospinal fluid β-amyloid 1-42 cutoffs in a large memory clinic population.

Authors:  Daniela Bertens; Betty M Tijms; Philip Scheltens; Charlotte E Teunissen; Pieter Jelle Visser
Journal:  Alzheimers Res Ther       Date:  2017-02-14       Impact factor: 6.982

10.  Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium.

Authors:  Irina Alafuzoff; Thomas Arzberger; Safa Al-Sarraj; Istvan Bodi; Nenad Bogdanovic; Heiko Braak; Orso Bugiani; Kelly Del-Tredici; Isidro Ferrer; Ellen Gelpi; Giorgio Giaccone; Manuel B Graeber; Paul Ince; Wouter Kamphorst; Andrew King; Penelope Korkolopoulou; Gábor G Kovács; Sergey Larionov; David Meyronet; Camelia Monoranu; Piero Parchi; Efstratios Patsouris; Wolfgang Roggendorf; Danielle Seilhean; Fabrizio Tagliavini; Christine Stadelmann; Nathalie Streichenberger; Dietmar R Thal; Stephen B Wharton; Hans Kretzschmar
Journal:  Brain Pathol       Date:  2008-03-26       Impact factor: 6.508

View more
  7 in total

Review 1.  The probabilistic model of Alzheimer disease: the amyloid hypothesis revised.

Authors:  Giovanni B Frisoni; Daniele Altomare; Dietmar Rudolf Thal; Federica Ribaldi; Rik van der Kant; Rik Ossenkoppele; Kaj Blennow; Jeffrey Cummings; Cornelia van Duijn; Peter M Nilsson; Pierre-Yves Dietrich; Philip Scheltens; Bruno Dubois
Journal:  Nat Rev Neurosci       Date:  2021-11-23       Impact factor: 34.870

Review 2.  Presenilin 1 Regulates Membrane Homeostatic Pathways that are Dysregulated in Alzheimer's Disease.

Authors:  Carol A Deaton; Gail V W Johnson
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

3.  Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer's Disease with APP Osaka Mutation.

Authors:  Hiroyuki Shimada; Shinobu Minatani; Jun Takeuchi; Akitoshi Takeda; Joji Kawabe; Yasuhiro Wada; Aya Mawatari; Yasuyoshi Watanabe; Hitoshi Shimada; Makoto Higuchi; Tetsuya Suhara; Takami Tomiyama; Yoshiaki Itoh
Journal:  Int J Mol Sci       Date:  2020-06-22       Impact factor: 5.923

4.  Gene mutations in a Han Chinese Alzheimer's disease cohort.

Authors:  Limin Ma; Jiewen Zhang; Yingying Shi; Wan Wang; Zhixia Ren; Mingrong Xia; Yuanxing Zhang; Miaomiao Yang
Journal:  Brain Behav       Date:  2018-12-14       Impact factor: 2.708

5.  Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans.

Authors:  Petronela Weisová; Ondrej Cehlár; Rostislav Škrabana; Monika Žilková; Peter Filipčík; Branislav Kováčech; Michal Prčina; Ľubica Wojčiaková; Ľubica Fialová; Tomáš Smolek; Eva Kontseková; Norbert Žilka; Michal Novák
Journal:  Acta Neuropathol Commun       Date:  2019-08-07       Impact factor: 7.801

6.  Variability in the type and layer distribution of cortical Aβ pathology in familial Alzheimer's disease.

Authors:  Nanet Willumsen; Teresa Poole; Jennifer M Nicholas; Nick C Fox; Natalie S Ryan; Tammaryn Lashley
Journal:  Brain Pathol       Date:  2021-07-28       Impact factor: 7.611

Review 7.  Cerebral Small Vessel Disease in Sporadic and Familial Alzheimer Disease.

Authors:  Rajesh N Kalaria; Diego Sepulveda-Falla
Journal:  Am J Pathol       Date:  2021-07-28       Impact factor: 4.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.